Stryker CEO to Address Challenges, Opportunities in Emerging Markets

Wednesday, October 20, 2021

Stryker Chair & CEO Kevin Lobo Keynotes the Ralph J. Gerson Distinguished Lecture

This article was updated to include the full discussion. 
Healthcare expenditure in low- and middle-income countries (LMICs) is soaring. This can result in significant health improvements while creating new opportunities for businesses operating in these markets in the coming decades. Innovations in medical technology, improved access and delivery of care are all factors in the growth, which show no signs of slowing.

The possibility and interest in serving these markets and helping to make healthcare better creates opportunities for job seekers, companies and healthcare professionals. However, organizations face significant challenges in developing business models that can provide quality products and services and do so profitably. As more companies are successful, the local communities and patients will continue to benefit.

The keynote speaker for WDI’s Ralph J. Gerson Distinguished Lecture, Kevin Lobo, Chair and CEO of Stryker, provided perspective and insights for innovating and driving growth in LMICs. With globalization as part of the company’s strategy, Lobo has continued to focus resources and talent on key global markets since becoming CEO of Stryker in 2012. Lobo’s talk focused on “Challenges and Opportunities for Healthcare Companies in Emerging Markets.”

Headquartered in Kalamazoo, MI, Stryker is one of the world’s leading medical technology companies, offering innovative products and services in orthopaedics, medical and surgical, and neurotechnology and spine that help improve patient and hospital outcomes.


Back to Top